Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Equity: 2021-2025

Historic Return on Equity for iSpecimen (ISPC) over the last 4 years, with Sep 2025 value amounting to -6.65%.

  • iSpecimen's Return on Equity fell 486.00% to -6.65% in Q3 2025 from the same period last year, while for Sep 2025 it was -6.65%, marking a year-over-year decrease of 486.00%. This contributed to the annual value of -1.97% for FY2024, which is 125.00% down from last year.
  • iSpecimen's Return on Equity amounted to -6.65% in Q3 2025, which was up 31.80% from -9.75% recorded in Q2 2025.
  • iSpecimen's 5-year Return on Equity high stood at -0.32% for Q2 2022, and its period low was -9.75% during Q2 2025.
  • Over the past 3 years, iSpecimen's median Return on Equity value was -1.57% (recorded in 2024), while the average stood at -2.90%.
  • In the last 5 years, iSpecimen's Return on Equity surged by 35bps in 2022 and then tumbled by 818bps in 2025.
  • Over the past 5 years, iSpecimen's Return on Equity (Quarterly) stood at -0.45% in 2021, then fell by 3bps to -0.48% in 2022, then slumped by 49bps to -0.97% in 2023, then slumped by 224bps to -3.20% in 2024, then crashed by 486bps to -6.65% in 2025.
  • Its last three reported values are -6.65% in Q3 2025, -9.75% for Q2 2025, and -4.63% during Q1 2025.